Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217009 · ClinicalTrials.gov registry record · Early Phase 1
Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.
A Early Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT00217009: Clinical Trial Early Phase 1 study, sponsored by Mayo Clinic.
NCT00217009 is a Early Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217009, a Early Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Hand and foot skin diseases, such as dermatitis and psoriasis, that do not respond to topical creams can be treated with ultraviolet light therapy. Topical psoralen plus ultraviolet A (PUVA) is commonly used to treat these conditions, but requires additional time for the hands and feet to soak in psoralens before the light treatment. Newer narrowband ultraviolet B (NBUVB) units have become available which allow for light treatment without soaking first. The purpose of this study is to determine if NBUVB is as effective as PUVA for hand and foot skin diseases.
Interventions
- PROCEDURE Narrowband Ultraviolet B (TL-01UVB) Therapy
- PROCEDURE Topical Psoralen plus ultraviolet A (PUVA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2005-03 |
| Est. Completion | 2008-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00217009
The ClinicalTrials.gov registry entry for NCT00217009 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Narrowband Ultraviolet B (TL-01UVB) Therapy is the first listed.
NCT00217009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00217009 about?
NCT00217009 is a clinical study titled "Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.". Hand and foot skin diseases, such as dermatitis and psoriasis, that do not respond to topical creams can be treated with ultraviolet light therapy. Topical psoralen plus ultraviolet A (PUVA) is commonly used to treat these conditions, but requires additional time for the hands and feet to soak in ps...
What is the current status of trial NCT00217009?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2005-03. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00217009?
The interventions under investigation include: Narrowband Ultraviolet B (TL-01UVB) Therapy (PROCEDURE), Topical Psoralen plus ultraviolet A (PUVA) (PROCEDURE).
Who is sponsoring clinical trial NCT00217009?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.